High risk of hypogonadism in young male cancer survivors.

S IsakssonK BogeforsO StåhlJ EberhardY L GiwercmanI LeijonhufvudK LinkI ØraP RomeriusJ BobjerA Giwercman

Published in: Clinical endocrinology (2018)

Biochemical signs of testosterone deficiency are recognized as markers of decreased life expectancy. Thus, the risk of hypogonadism in TCS and CCS should be recognized and emphasizes the need of long-term follow-up for these men.

Keyphrases

replacement therapy
middle aged
smoking cessation
young adults
childhood cancer